NPI registry status
Active
2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1023198793 D.D.S.MSC
Verify on CMS → Robert Dolman, D.D.S.MSC
Oral and Maxillofacial Pathology Dentistry in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 678 in Oral and Maxillofacial Pathology Dentistry, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
162
Medicare Part D claims · 58 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 299
Industry payments
$65.84
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Robert Dolman, D.D.S.MSC filed 162 Medicare Part D claims in 2024 as an Oral and Maxillofacial Pathology Dentistry in New York, New York.
- 162
- Part D claims, 2024
- $65.84
- industry payments (Sunshine Act)
- ≥34th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Robert Dolman, D.D.S.MSC
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1023198793), first enumerated 10/17/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 162 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Industry payment transparency
$65.84 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Robert Dolman, D.D.S.MSC's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1023198793 · Oral and Maxillofacial Pathology Dentistry
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1023198793
- ENUM-LEGACY 2006
- TAX-NARROW 678
- RX-LIGHT 162
- BOOK-THIN 67 in New York
- PHOTO-ENUM David Wells, D.D.S.,… · 2006
Robert Dolman, D.D.S.MSC's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
162 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Robert Dolman, D.D.S.MSC?
Quality data not reportedPrimary specialty
Oral and Maxillofacial Pathology Dentistry
Medicare Part D claims
162 46% vs specialty avg
Specialty distribution in New York
How Oral and Maxillofacial Pathology Dentistry compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oral and Maxillofacial Pathology Dentistry. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1023198793 |
|---|---|
| Specialty | Oral and Maxillofacial Pathology Dentistry |
| Credentials | D.D.S.MSC |
| Gender | Male |
| NPI Issued | 10/17/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Dolman, D.D.S.MSC. Source: openpaymentsdata.cms.gov.
Total received
$66
Largest payer
Southern Anesthesia & Surgical, Inc (dba Ace Southern)
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Robert Dolman, D.D.S.MSC. To verify Robert Dolman, D.D.S.MSC's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
162
Total Claims
$731
Total Drug Cost
58
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 162
- Total Day Supply
- 1,202
- Brand Drug Cost
- $0
- Generic Drug Cost
- $731
- Opioid Claims
- 13 (8.0% rate)
- Antibiotic Claims
- 62
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 0.77
- Gender Split
- 72% female / 28% male
- Age Distribution
- <65: 0, 65-74: 30, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Robert Dolman, D.D.S.MSC prescribes most
Top Medicare Part D drugs by claim count, 2024
- Amoxicillin
Amoxicillin
47 claims
- Ibuprofen
Ibuprofen
40 claims
- Chlorhexidine Gluc…
Chlorhexidine Gluconate
29 claims
- Oxycodone-Acetamin… 13
Oxycodone-Acetaminophen
13 claims
| Drug | Claims |
|---|---|
| Amoxicillin | 47 |
| Ibuprofen | 40 |
| Chlorhexidine Gluconate | 29 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Oral and Maxillofacial Pathology Dentistry in NY →
All providers in New York →
Compare specialties →
Oral and Maxillofacial Pathology Dentistry Overview
How Robert Dolman, D.D.S.MSC fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.
678
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
299
Avg Claims per Provider
Robert Dolman, D.D.S.MSC's 162 claims are below the specialty average of 299.
Nationwide Oral and Maxillofacial Pathology Dentistry peers with similar MIPS or enrollment year
Two federal-record peer sets for Dolman, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Oral and Maxillofacial Pathology Dentistry Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Dolman.
One of 67 Oral and Maxillofacial Pathology Dentistry providers enrolled in New York, 5 are shown here.
Dr. Hillel Abramov
DDS
Elmhurst, NY
Dr. Alfredo Aguirre
DDS
Buffalo, NY
Dr. Erhard Beuttenmuller
DDS
Fort Drum, NY
Dr. Beth Boguslaw
DMD
Bronx, NY
Dr. Robert Bowe
DDS
Staten Island, NY
Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →
Frequently Asked Questions
What is Robert Dolman, D.D.S.MSC's specialty? ▼
Robert Dolman, D.D.S.MSC specializes in Oral and Maxillofacial Pathology Dentistry and practices in New York, New York. Credentials: D.D.S.MSC.
How much does Robert Dolman, D.D.S.MSC prescribe under Medicare Part D? ▼
In 2024, Robert Dolman, D.D.S.MSC wrote 162 Medicare Part D claims totaling $731 in drug costs for 58 beneficiaries.
Where is Robert Dolman, D.D.S.MSC located? ▼
Robert Dolman, D.D.S.MSC is located at 12 E 41ST ST, New York, NY, 10017. Phone: (212) 696-0167.
What is Robert Dolman, D.D.S.MSC's NPI number? ▼
Robert Dolman, D.D.S.MSC's National Provider Identifier (NPI) is 1023198793, issued on 10/17/2006.
Does Robert Dolman, D.D.S.MSC prescribe opioids? ▼
Yes, Robert Dolman, D.D.S.MSC had 13 opioid claims in 2024 with an opioid prescribing rate of 8.0%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US? ▼
There are 678 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 299 Medicare Part D claims per year.
What drugs does Robert Dolman, D.D.S.MSC prescribe most often? ▼
Based on 2024 Medicare Part D data, Robert Dolman, D.D.S.MSC's most frequently prescribed drugs include Amoxicillin, Ibuprofen, Chlorhexidine Gluconate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Dolman, D.D.S.MSC accept Medicare? ▼
Robert Dolman, D.D.S.MSC appears in CMS Medicare data with 162 Part D claims and 58 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Dolman, D.D.S.MSC's credentials? ▼
Robert Dolman, D.D.S.MSC's NPI is 1023198793 with credentials D.D.S.MSC. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.